LeadIQ logo
Learn more at LeadIQ.com

Insights

Expansion Opportunities ADC Therapeutics has secured funding of $105M, indicating financial stability and potential for expansion and investment in new markets or technologies.

Collaborative Partnerships Recent partnerships with companies like Intocell and Avidbio showcase opportunities for collaboration and potential sales growth through combined efforts and expanded product offerings.

Market Penetration With ADC Therapeutics focusing on treatments for lymphoma and tumors, there is a significant market opportunity to penetrate and capture a share in these specific healthcare segments.

Incentivized Workforce Introduction of a new employee incentive plan in February 2024 suggests a motivated workforce, potentially leading to increased productivity and innovative sales strategies.

Clinical Trial Results The Phase II data release for ZYNLONTA in May 2024 demonstrating high rates of treatment response paves the way for increased sales by showcasing the effectiveness of ADC Therapeutics' products.

Similar companies to ADC Therapeutics

ADC Therapeutics Tech Stack

ADC Therapeutics uses 8 technology products and services including Cloudflare, Typekit, Mustache, and more. Explore ADC Therapeutics's tech stack below.

  • Cloudflare
    Content Management System
  • Typekit
    Font Scripts
  • Mustache
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Windows Server
    Operating Systems
  • New Relic
    Real User Monitoring
  • HSTS
    Security
  • Twitter
    Widgets

Media & News

ADC Therapeutics's Email Address Formats

ADC Therapeutics uses at least 1 format(s):
ADC Therapeutics Email FormatsExamplePercentage
First.Last@adctherapeutics.comJohn.Doe@adctherapeutics.com
96%
Last@adctherapeutics.comDoe@adctherapeutics.com
3%
First.MiddleLast@adctherapeutics.comJohn.MichaelDoe@adctherapeutics.com
1%

Frequently Asked Questions

Where is ADC Therapeutics's headquarters located?

Minus sign iconPlus sign icon
ADC Therapeutics's main headquarters is located at Lausanne, Vaud, Switzerland CH. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is ADC Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact ADC Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ADC Therapeutics's stock symbol?

Minus sign iconPlus sign icon
ADC Therapeutics is a publicly traded company; the company's stock symbol is ADCT.

What is ADC Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
ADC Therapeutics's official website is adctherapeutics.com and has social profiles on LinkedIn.

How much revenue does ADC Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2024, ADC Therapeutics's annual revenue reached $75M.

What is ADC Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
ADC Therapeutics's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ADC Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2024, ADC Therapeutics has approximately 307 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Technology Officer: D. E.Chief People Officer: K. P.Chief Medical Officer, Svp: M. Z.. Explore ADC Therapeutics's employee directory with LeadIQ.

What industry does ADC Therapeutics belong to?

Minus sign iconPlus sign icon
ADC Therapeutics operates in the Biotechnology Research industry.

What technology does ADC Therapeutics use?

Minus sign iconPlus sign icon
ADC Therapeutics's tech stack includes CloudflareTypekitMustachejQueryWindows ServerNew RelicHSTSTwitter.

What is ADC Therapeutics's email format?

Minus sign iconPlus sign icon
ADC Therapeutics's email format typically follows the pattern of . Find more ADC Therapeutics email formats with LeadIQ.

How much funding has ADC Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2024, ADC Therapeutics has raised $105M in funding. The last funding round occurred on May 06, 2024 for $105M.
ADC Therapeutics

ADC Therapeutics

Biotechnology ResearchVaud, Switzerland, Switzerland201-500 Employees

ADC Therapeutics is a commercial-stage global pioneer in the field of antibody drug conjugates (ADCs). 
 
Our goal is to be a leading ADC company that transforms the lives of those impacted by cancer. To achieve this, we are focused on unlocking the potential value of our robust ADC portfolio across two pillars of growth: hematology and solid tumors. We are a pioneer in the ADC field with specialized end-to-end capabilities unique to ADCs including a validated technology platform, a growing next-generation research & development toolbox and a proven track record that includes an approved and marketed product. We aim to expand our portfolio and accelerate the development of our pipeline through targeted investments and in collaboration with strategic partners. In this way, we plan to pursue multiple targets in parallel, enabling us to prioritize and ensure disciplined capital allocation strategy while advancing the most promising candidates in both hematology and solid tumors.

Our CD19-directed ADC ZYNLONTA® (loncastuximab tesirine-lpyl) received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy. ZYNLONTA is also in development in combination with other agents and in earlier lines of therapy.

Founded in 2011, ADC Therapeutics is based in Lausanne, Switzerland, with operations in London and New Jersey. Our highly skilled global team is committed to confronting cancer with the full potential of our science and transforming the treatment paradigm for patients with cancer.

For more information, please visit https://www.adctherapeutics.com/.

Section iconCompany Overview

Headquarters
Lausanne, Vaud, Switzerland CH
Phone number
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
ADCT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
201-500

Section iconFunding & Financials

  • $105M

    ADC Therapeutics has raised a total of $105M of funding over 11 rounds. Their latest funding round was raised on May 06, 2024 in the amount of $105M.

  • $50M$100M

    ADC Therapeutics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $105M

    ADC Therapeutics has raised a total of $105M of funding over 11 rounds. Their latest funding round was raised on May 06, 2024 in the amount of $105M.

  • $50M$100M

    ADC Therapeutics's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.